MTHFD2 and glioblastoma: MTHFD2 is broadly required for cancer cell proliferation and viability as a metabolic enzyme and was overexpressed around the tumor regions with poor nutrient access in GBM patients, and the suppression of MTHFD2 could cause cancer cell death (Tanaka et al., 2021).